These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1591913)

  • 41. A comparative study of thought disorder in acute and chronic schizophrenia.
    Mazumdar PK; Chaturvedi SK; Gopinath PS
    Psychopathology; 1995; 28(4):185-9. PubMed ID: 7480574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Congruence between the Frankfurt Complaint Inventory and the clinical rating of schizophrenic patients].
    Gmür M
    Nervenarzt; 1987 Jun; 58(6):365-8. PubMed ID: 3614474
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of negative symptoms in schizophrenic and poor outcome bipolar patients.
    Reddy R; Mukherjee S; Schnur DB
    Psychol Med; 1992 May; 22(2):361-5. PubMed ID: 1615103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scale for Assessment of Thought, Language and Communication in psychotic in-patients.
    Mazumdar PK; Chaturvedi SK; Sinha V; Gopinath PS
    Psychopathology; 1991; 24(4):199-202. PubMed ID: 1754650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-rank symptoms or rank-and-file symptoms?
    Crichton P
    Br J Psychiatry; 1996 Nov; 169(5):537-40; discussion 541-50. PubMed ID: 8932880
    [No Abstract]   [Full Text] [Related]  

  • 47. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
    J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.
    Purnine DM; Carey KB; Maisto SA; Carey MP
    J Nerv Ment Dis; 2000 Oct; 188(10):653-61. PubMed ID: 11048814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic criteria for schizophrenia and related disorders: options for DSM-IV.
    Flaum M; Andreasen NC
    Schizophr Bull; 1991; 17(1):133-56. PubMed ID: 2047783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms.
    Lindenmayer JP; Grochowski S; Kay SR
    Compr Psychiatry; 1991; 32(6):528-33. PubMed ID: 1778080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the 16-item Negative Symptom Assessment.
    Axelrod BN; Goldman RS; Alphs LD
    J Psychiatr Res; 1993; 27(3):253-8. PubMed ID: 7905033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prototypal view of diagnosis: predictive validity of diagnostic certainty for schizophrenia.
    Roff JD; Knight RA
    Psychol Rep; 1996 Dec; 79(3 Pt 2):1289-90. PubMed ID: 9009780
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression.
    Sax KW; Strakowski SM; Keck PE; Upadhyaya VH; West SA; McElroy SL
    Br J Psychiatry; 1996 Jan; 168(1):68-71. PubMed ID: 8770431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A polydiagnostic approach to self-perceived cognitive disorders in schizophrenia.
    Peralta V; Cuesta MJ
    Psychopathology; 1992; 25(5):232-8. PubMed ID: 1293622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
    Wetzel H; Hillert A; Gründer G; Benkert O
    Am J Psychiatry; 1994 Oct; 151(10):1499-502. PubMed ID: 7916543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrent and predictive validity of components of disordered thinking in schizophrenia.
    Knight RA; Elliott DS; Roff JD; Watson CG
    Schizophr Bull; 1986; 12(3):427-46. PubMed ID: 3764360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.